日内瓦湖区长期无创通气:适应症、患病率与模式
该横断面观察研究纳入日内瓦和沃州所有接受无创通气(NIV)的489例患者,描述15年间NIV患病率与适应症变化。NIV患病率较2000年增加2.5倍,达38/10万居民;中位年龄71岁,31%超过75岁,平均3±1.8种合并症,55%肥胖。COPD(含重叠综合征)为最主要患者组,其次为肥胖低通气综合征(OHS,26%)。
要点
- NIV患病率15年间增加2.5倍,达38/10万居民。
- COPD是首位适应症,其次为OHS(26%)。
- 患者老龄化、合并症多且肥胖常见,仅8%依从性<3.5 h/d。
核心结论
- 该地区NIV使用快速增加,治疗人群呈现老龄化、多合并症和肥胖特征,COPD为当前首位适应症,其次为OHS。
研究设计与样本
- 横断面观察研究,设计纳入日内瓦和沃州(1,288,378名居民)所有参与NIV的机构随访的全部NIV治疗者,共纳入489例患者。
主要发现
- NIV患病率自2000年以来增加2.5倍,达到38/10万居民。
- 患者中位年龄71岁,31%超过75岁;接受NIV中位时间39个月,平均合并症3±1.8种,55%为肥胖。
- COPD(包括重叠综合征)为最主要患者组,其次为OHS(26%)。
- 日间Paco2多已正常化;仅8%患者每日使用设备<3.5小时。
- 双水平正压通气 spontaneous/timed 模式为默认模式(86%),自动滴定模式使用较少。
关键数值与推荐
- NIV启动方式:50%为择期启动,82%在医院环境中启动,15%在门诊启动。
- 治疗依从性:仅8%患者每日使用NIV<3.5小时。
- 通气模式:86%使用双水平正压通气 spontaneous/timed 模式。
临床怎么用
- 临床中应关注NIV治疗人群的老龄化、多合并症及肥胖特征,并评估COPD与OHS等主要适应症。
- 多数患者日间Paco2可正常化,依从性总体满意,可参考该人群特征优化随访与设备模式选择。
局限性
- 本研究为横断面观察设计,未报告纵向因果关联或干预效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Noninvasive ventilation (NIV) is standard of care for chronic hypercapnic respiratory failure, but indications, devices, and ventilatory modes are in constant evolution. RESEARCH QUESTION: To describe changes in prevalence and indications for NIV over a 15-year period; to provide a comprehensive report of characteristics of the population treated (age, comorbidities, and anthropometric data), mode of implementation and follow-up, devices, modes and settings used, physiological data, compliance, and data from ventilator software. STUDY DESIGN AND METHODS: Cross-sectional observational study designed to include all subjects under NIV followed by all structures involved in NIV in the Cantons of Geneva and Vaud (1,288,378 inhabitants). RESULTS: A total of 489 patients under NIV were included. Prevalence increased 2.5-fold since 2000 reaching 38 per 100,000 inhabitants. Median age was 71 years, with 31% being > 75 years of age. Patients had been under NIV for a median of 39 months and had an average of 3 ± 1.8 comorbidities; 55% were obese. COPD (including overlap syndrome) was the most important patient group, followed by obesity hypoventilation syndrome (OHS) (26%). Daytime Paco2 was most often normalized. Adherence to treatment was satisfactory, with 8% only using their device < 3.5 h/d. Bilevel positive pressure ventilators in spontaneous/timed mode was the default mode (86%), with a low use of autotitrating modes. NIV was initiated electively in 50% of the population, in a hospital setting in 82%, and as outpatients in 15%. INTERPRETATION: Use of NIV is increasing rapidly in this area, and the population treated is aging, comorbid, and frequently obese. COPD is presently the leading indication followed by OHS. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT04054570; URL: www.clinicaltrials.gov.
引用
- Cantero C, Adler D, Pasquina P, et al. Long-Term Noninvasive Ventilation in the Geneva Lake Area: Indications, Prevalence, and Modalities. Chest. 2020. PMID: 32243941. doi:10.1016/j.chest.2020.02.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。